Catalyst Wire Dossier Catalyst Wire Dossier

DRV/r + maraviroc + Kivexa

darunavir boosted with ritonavir + maraviroc + abacavir/lamivudine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DRV/r + maraviroc + Kivexa, covering 2019-10-21 to 2019-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa [Phase 4]

See pricing